DEUTSCHE BANK AG\ - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 60 filers reported holding OBALON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$5,000
-92.2%
1,800
-94.0%
0.00%
Q2 2018$64,000
+16.4%
30,054
+82.0%
0.00%
Q1 2018$55,000
-60.1%
16,509
-21.8%
0.00%
Q4 2017$138,000
+86.5%
21,120
+170.4%
0.00%
Q3 2017$74,000
-15.9%
7,811
-13.6%
0.00%
Q2 2017$88,000
-14.6%
9,036
-6.9%
0.00%
Q1 2017$103,000
+22.6%
9,705
+0.7%
0.00%
Q4 2016$84,0009,6370.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$23,380,0006.09%
Tamarack Advisers, LP 547,536$5,218,0003.20%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,149,0000.28%
Moisand Fitzgerald Tamayo, LLC 6,875$281,0000.17%
FORMULA GROWTH LTD 108,998$1,039,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 351,284$3,348,0000.15%
KORNITZER CAPITAL MANAGEMENT INC /KS 423,390$4,035,0000.07%
TIVERTON ASSET MANAGEMENT LLC 123,800$1,179,0000.07%
Granite Investment Partners, LLC 108,758$1,036,0000.06%
Bellevue Group AG 48,000$457,0000.05%
View complete list of OBALON THERAPEUTICS INC shareholders